Sensors that detect plant signaling molecules can reveal when crops are experiencing too much light or heat, or attack from insects or microbes.

A catalyst tethered by DNA boosts the efficiency of the electrochemical conversion of CO2 to CO, a building block for many chemical compounds.

Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.

Study shows metal-organic particles can both deliver vaccines and act as an adjuvant to generate a strong immune response at a lower dose.

Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.

The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.

MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.

Using generative AI, MIT chemists created a model that can predict the structures formed when a chemical reaction reaches its point of no return.

Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.

Core-shell structures made of hydrogel could enable more efficient uptake in the body.